Spots Global Cancer Trial Database for Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
Official Title: Phase 2 Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
Study ID: NCT05070403
Conditions
Interventions
Study Description
Brief Summary: The primary purpose of this study is to find out if Afatinib can help treat participants with advanced cSCC.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Moffitt Cancer Center, Tampa, Florida, United States
Contact Details
Name: Zeynep Eroglu, MD
Affiliation: Moffitt Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
